a href=http://wwwharrisonsandcrosfieldcomContact:CherylwwwharrisonsandcrosfieldcomContact:Cheryl/a Roberto Carlos a href=http://www

divulges Roberto Carlos Phone: roberto carlos fenerbahce reasons 973-463-0420Fax:973-463-0430SOURCEHarrisons & Crosfield TeasCheryl Templeton of Harrisons & Crosfield Teas, +1-973-463-0420, Fax,+1-973-463-0430, . FAIRFIELD, Conn., Jan 12, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies,Inc. (NYSE:CTT) announced today that it has received a sales order from ExcelLife Sciences, Inc (ELS) for pain management therapy devices. The device is anon-invasive method for rapid treatment of high-intensity oncologic andneuropathic pain, including pain resistant to morphine and other drugs.

ELS,CTT's country-exclusive distributor in India, recognizing the benefits of theinnovative device, was the first announced healthcare services provider to signa distribution agreement for the device discografia roberto carlos . Subsequent distribution agreementsgranted country-exclusive distribution rights to GEOMC Co., Ltd roberto carlos goals . for Korea, toAG Healthcare for Malaysia, and to Biogene Pharma Limited for Bangladesh.The order from ELS has an approximate retail value of up to $1 million roberto carlos discography . Shipmentof the devices to ELS is scheduled to begin immediately.ELS is a U.S.-based, India-focused provider of clinical research and healthcareservices roberto carlos torrents .

They have a special focus on improving patient care in the markets inwhich they operate roberto carlos musica . ELS has a fully-owned Indian subsidiary with its main officein New Delhi, and 21 operational locations serving a network of over 700hospitals across India.The CTT device has Medical Device CE certification from the European Unionallowing sales of the device throughout Europe and several other countries,including India roberto carlos en espanol . Approval of CTT's pending FDA 510(k) medical device applicationwill authorize U.S sales of the device reberto carlos . The review and selection process fordistributors in Europe, Asia, the U.S and Latin America is continuing roberto carlos jesus cristo lyrics . CTT hasexclusive worldwide rights to this patented device.Dr. Vijai Kumar, ELS's President and Chief Medical Officer, said, "We have seenthis device in action, and have witnessed its pain relieving capabilities. ELSis starting formal clinical studies using this new pain management device atfour leading healthcare facilities in India within the month The protocol forthese studies will follow U.S.

FDA guidelines and treat a total of 160 patientsdivided into four specific neuropathies . We expect this new device to initiate aparadigm shift in the perception and treatment of pain in India roberto carlos freekick . There are overfour million people in the country suffering from severe cancer, neuropathicpain and other forms of chronic disabling pain."Mohit Mehrotra, ELS's Founder and Chief Operating Officer, commented, "We areproud to work with CTT to bring this progressive medical technology to India roberto carlos music . Weare focusing considerable resources on this technology and our relationship withCTT .